Delivery Order SPE2DB22D3301-SPE2DB26FX3RM
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,051.36 by the Defense Logistics Agency (DLA) for the supply of Clobazam 10 mg tablets (100 count) to be performed at the contractor's facility in Conshohocken, Pennsylvania. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 20, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,552.54 by the Defense Logistics Agency (DLA) on July 14, 2025, with an ultimate completion date of July 15, 2025. The contract calls for the delivery of Clobazam 10 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $8,907.91 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets in quantities of 100 units. This firm fixed-price contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $7,261.81. This firm fixed-price delivery order, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger contract vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $3,111.86. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is September 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $1,654.99. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $1,015.46 under a firm fixed price contract. This award represents a non-set-aside competitive procurement processed as a delivery order, with an ultimate completion date of September 25, 2025. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will serve as the place of performance...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on June 24, 2025, for the supply of Clobazam 10 mg tablets (100-count units) at a firm fixed price of $8,969.05. The contract, which is a non-set-aside competitive award with a completion date of June 25, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical support vehicle with the DLA. The place of performance is the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.42 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) on August 11, 2025, with a completion date of August 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units. This delivery order represents a single transaction with a firm fixed price ceiling value of $3,111.86 and an ultimate completion date of September 18, 2025. The award was made through open competition with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3RMDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,975.56 by the Defense Logistics Agency (DLA) on October 22, 2025, for the supply of Clobazam 10 mg tablets (100-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains through its relationship with the DLA Medical Supply Chain. The company's federal procurement track record demonstrates consistent capability to fulfill competitive requirements for both brand-name and generic medications, vaccines, and specialized medical commodities across small- to large-value transactions. This delivery order for Clobazam, an anticonvulsant medication used in neurological treatment, reflects the company's ongoing role as a key supplier to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 10/22/25 |